nodes	percent_of_prediction	percent_of_DWPC	metapath
Ridogrel—TBXAS1—leg—multiple sclerosis	0.152	0.695	CbGeAlD
Ridogrel—TBXA2R—Small Ligand GPCRs—S1PR1—multiple sclerosis	0.0674	0.0862	CbGpPWpGaD
Ridogrel—TBXA2R—Prostanoid ligand receptors—PTGER4—multiple sclerosis	0.0619	0.0793	CbGpPWpGaD
Ridogrel—TBXA2R—Eicosanoid ligand-binding receptors—PTGER4—multiple sclerosis	0.0412	0.0527	CbGpPWpGaD
Ridogrel—TBXAS1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.0353	0.0452	CbGpPWpGaD
Ridogrel—TBXAS1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.0353	0.0452	CbGpPWpGaD
Ridogrel—TBXA2R—Small Ligand GPCRs—PTGER4—multiple sclerosis	0.0341	0.0436	CbGpPWpGaD
Ridogrel—TBXA2R—Small Ligand GPCRs—CNR1—multiple sclerosis	0.0295	0.0378	CbGpPWpGaD
Ridogrel—TBXAS1—Prostaglandin Synthesis and Regulation—PTGER4—multiple sclerosis	0.0292	0.0374	CbGpPWpGaD
Ridogrel—TBXAS1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.0286	0.0366	CbGpPWpGaD
Ridogrel—TBXAS1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.0286	0.0366	CbGpPWpGaD
Ridogrel—TBXAS1—nervous system—multiple sclerosis	0.0185	0.0849	CbGeAlD
Ridogrel—TBXAS1—central nervous system—multiple sclerosis	0.0178	0.0817	CbGeAlD
Ridogrel—TBXA2R—Thromboxane A2 receptor signaling—SELE—multiple sclerosis	0.0173	0.0222	CbGpPWpGaD
Ridogrel—TBXA2R—brain—multiple sclerosis	0.0161	0.0739	CbGeAlD
Ridogrel—TBXAS1—Biological oxidations—CYP27B1—multiple sclerosis	0.0152	0.0195	CbGpPWpGaD
Ridogrel—TBXAS1—Biological oxidations—CYP24A1—multiple sclerosis	0.0152	0.0195	CbGpPWpGaD
Ridogrel—TBXAS1—brain—multiple sclerosis	0.0142	0.0649	CbGeAlD
Ridogrel—TBXA2R—Thromboxane A2 receptor signaling—VCAM1—multiple sclerosis	0.0109	0.014	CbGpPWpGaD
Ridogrel—TBXA2R—G alpha (q) signalling events—GPR65—multiple sclerosis	0.00872	0.0112	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	0.0082	0.0105	CbGpPWpGaD
Ridogrel—TBXAS1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.00794	0.0102	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—multiple sclerosis	0.0078	0.00998	CbGpPWpGaD
Ridogrel—TBXA2R—Thromboxane A2 receptor signaling—ICAM1—multiple sclerosis	0.00742	0.0095	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.00716	0.00916	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—SELPLG—multiple sclerosis	0.00685	0.00876	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—MERTK—multiple sclerosis	0.00685	0.00876	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—CD58—multiple sclerosis	0.00685	0.00876	CbGpPWpGaD
Ridogrel—TBXA2R—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.00674	0.00862	CbGpPWpGaD
Ridogrel—TBXAS1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.00644	0.00824	CbGpPWpGaD
Ridogrel—TBXA2R—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.00616	0.00789	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.00584	0.00747	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.00584	0.00747	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.00577	0.00739	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—S1PR1—multiple sclerosis	0.00545	0.00698	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.00528	0.00676	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.00528	0.00676	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—GPR65—multiple sclerosis	0.0044	0.00563	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—PLEK—multiple sclerosis	0.00423	0.00541	CbGpPWpGaD
Ridogrel—TBXA2R—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.00423	0.00541	CbGpPWpGaD
Ridogrel—TBXA2R—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.00408	0.00522	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—CXCL13—multiple sclerosis	0.00402	0.00515	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—CCR1—multiple sclerosis	0.00402	0.00515	CbGpPWpGaD
Ridogrel—TBXA2R—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.00397	0.00508	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.00376	0.00481	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—SRM—multiple sclerosis	0.00369	0.00472	CbGpPWpGaD
Ridogrel—TBXA2R—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.00367	0.00469	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.00362	0.00463	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.0035	0.00448	CbGpPWpGaD
Ridogrel—TBXAS1—Biological oxidations—POMC—multiple sclerosis	0.00342	0.00438	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.0034	0.00435	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.00314	0.00402	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00308	0.00394	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—SELE—multiple sclerosis	0.00298	0.00381	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—CCL3—multiple sclerosis	0.00287	0.00367	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	0.00285	0.00365	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00283	0.00362	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—S1PR1—multiple sclerosis	0.0028	0.00358	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—PTGER4—multiple sclerosis	0.00276	0.00353	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—CXCR3—multiple sclerosis	0.00266	0.00341	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—RGS1—multiple sclerosis	0.00262	0.00335	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CYP27B1—multiple sclerosis	0.0026	0.00333	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CYP24A1—multiple sclerosis	0.0026	0.00333	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—CCR2—multiple sclerosis	0.00259	0.00332	CbGpPWpGaD
Ridogrel—TBXA2R—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.00256	0.00327	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.00254	0.00325	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—GPR65—multiple sclerosis	0.00248	0.00318	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.00243	0.00311	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—CNR1—multiple sclerosis	0.00239	0.00306	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—RGS1—multiple sclerosis	0.00238	0.00305	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—GPC5—multiple sclerosis	0.00238	0.00304	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CCR1—multiple sclerosis	0.00227	0.00291	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00227	0.00291	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—GPR65—multiple sclerosis	0.00226	0.00289	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00219	0.00281	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—LINGO1—multiple sclerosis	0.00218	0.00279	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—ITGA4—multiple sclerosis	0.00215	0.00276	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—CXCL10—multiple sclerosis	0.00215	0.00275	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—IFNB1—multiple sclerosis	0.00214	0.00274	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	0.00206	0.00264	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CXCL13—multiple sclerosis	0.00206	0.00264	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CCR1—multiple sclerosis	0.00206	0.00264	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.00206	0.00263	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—RRM1—multiple sclerosis	0.00197	0.00252	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TAGAP—multiple sclerosis	0.00189	0.00242	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—CCL5—multiple sclerosis	0.00185	0.00237	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00171	0.00219	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00168	0.00215	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	0.00167	0.00214	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—CCR5—multiple sclerosis	0.00167	0.00214	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—S1PR1—multiple sclerosis	0.00165	0.00212	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—GPC5—multiple sclerosis	0.00161	0.00206	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PTGER4—multiple sclerosis	0.00156	0.00199	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.00153	0.00196	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00151	0.00193	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—IL2RA—multiple sclerosis	0.00147	0.00188	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CCL3—multiple sclerosis	0.00147	0.00188	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CCR2—multiple sclerosis	0.00146	0.00187	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PTGER4—multiple sclerosis	0.00142	0.00181	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—RGS1—multiple sclerosis	0.00141	0.0018	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CXCR3—multiple sclerosis	0.00137	0.00175	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CNR1—multiple sclerosis	0.00135	0.00173	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—GPR65—multiple sclerosis	0.00133	0.00171	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CCR2—multiple sclerosis	0.00133	0.0017	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.00131	0.00168	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.00131	0.00167	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	0.00131	0.00167	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—POMC—multiple sclerosis	0.00131	0.00167	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	0.00128	0.00164	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—CCL2—multiple sclerosis	0.00128	0.00163	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CNR1—multiple sclerosis	0.00123	0.00157	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CCR1—multiple sclerosis	0.00122	0.00156	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CXCL13—multiple sclerosis	0.00122	0.00156	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00122	0.00156	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.0012	0.00153	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—BCHE—multiple sclerosis	0.00113	0.00145	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CXCL10—multiple sclerosis	0.0011	0.00141	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—ALB—multiple sclerosis	0.00106	0.00136	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CCL5—multiple sclerosis	0.00105	0.00134	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.00101	0.00129	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CCL5—multiple sclerosis	0.000951	0.00122	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CCR5—multiple sclerosis	0.000944	0.00121	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—IL2RA—multiple sclerosis	0.00093	0.00119	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CCL3—multiple sclerosis	0.000869	0.00111	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—IL2—multiple sclerosis	0.000863	0.0011	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CCR5—multiple sclerosis	0.000857	0.0011	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—IL2RA—multiple sclerosis	0.000845	0.00108	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PTGER4—multiple sclerosis	0.000836	0.00107	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PGR—multiple sclerosis	0.000823	0.00105	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CXCR3—multiple sclerosis	0.000808	0.00103	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CD28—multiple sclerosis	0.0008	0.00102	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CCR2—multiple sclerosis	0.000786	0.00101	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—POMC—multiple sclerosis	0.000738	0.000944	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CNR1—multiple sclerosis	0.000725	0.000928	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—APOE—multiple sclerosis	0.000681	0.000871	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—TGFB1—multiple sclerosis	0.000673	0.000861	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—POMC—multiple sclerosis	0.00067	0.000857	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—MAPK1—multiple sclerosis	0.00066	0.000844	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CCL2—multiple sclerosis	0.000655	0.000838	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CXCL10—multiple sclerosis	0.000653	0.000835	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—TYK2—multiple sclerosis	0.000595	0.000761	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—POMC—multiple sclerosis	0.000585	0.000749	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CD86—multiple sclerosis	0.000571	0.00073	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CCL5—multiple sclerosis	0.000562	0.000719	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—IL2—multiple sclerosis	0.000545	0.000698	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—ALB—multiple sclerosis	0.000533	0.000682	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SPP1—multiple sclerosis	0.00052	0.000666	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CCR5—multiple sclerosis	0.000506	0.000648	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—IL2RA—multiple sclerosis	0.000499	0.000638	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—IL2—multiple sclerosis	0.000495	0.000634	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—APOE—multiple sclerosis	0.000461	0.000589	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CD80—multiple sclerosis	0.000416	0.000533	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—POMC—multiple sclerosis	0.000396	0.000506	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CCL2—multiple sclerosis	0.000387	0.000495	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—MAPK1—multiple sclerosis	0.000379	0.000485	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TYK2—multiple sclerosis	0.000352	0.00045	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—IL2—multiple sclerosis	0.000292	0.000374	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—IL6—multiple sclerosis	0.000291	0.000372	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MMP9—multiple sclerosis	0.000277	0.000354	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—STAT3—multiple sclerosis	0.000246	0.000315	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MYC—multiple sclerosis	0.000229	0.000293	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TGFB1—multiple sclerosis	0.000228	0.000292	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MAPK1—multiple sclerosis	0.000224	0.000286	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—IL6—multiple sclerosis	0.000172	0.00022	CbGpPWpGaD
